Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 2838

1.

Renal Denervation Suppresses Atrial Fibrillation in a Model of Renal Impairment.

Liang Z, Shi XM, Liu LF, Chen XP, Shan ZL, Lin K, Li J, Chen FK, Li YG, Guo HY, Wang YT.

PLoS One. 2015 Apr 17;10(4):e0124123. doi: 10.1371/journal.pone.0124123. eCollection 2015.

PMID:
25884946
2.

[Resumption of antithrombotic treatment after an intracerebral haemorrhage].

Kappelle LJ, Hofmeijer J, Chamuleau SA, Nieuwenhuizen KM, Hemels ME, Klijn CJ.

Ned Tijdschr Geneeskd. 2015;159(0):A8507. Dutch.

PMID:
25873219
3.

Low resting heart rates are associated with new-onset atrial fibrillation in patients with vascular disease: results of the ONTARGET/TRANSCEND studies.

Böhm M, Schumacher H, Linz D, Reil JC, Ukena C, Lonn E, Teo K, Sliwa K, Schmieder RE, Sleight P, Yusuf S.

J Intern Med. 2015 Apr 15. doi: 10.1111/joim.12373. [Epub ahead of print]

PMID:
25872921
4.

Should Oscillometric Blood Pressure Monitors Be Used in Patients With Atrial Fibrillation?

Myers MG, Stergiou GS.

J Clin Hypertens (Greenwich). 2015 Apr 9. doi: 10.1111/jch.12545. [Epub ahead of print] No abstract available.

PMID:
25865223
5.

Incremental value of left atrial structural and functional characteristics for prediction of atrial fibrillation in patients receiving cardiac pacing.

Kosmala W, Saito M, Kaye G, Negishi K, Linker N, Gammage M, Marwick TH; Protect-Pace Investigators.

Circ Cardiovasc Imaging. 2015 Apr;8(4). pii: e002942. doi: 10.1161/CIRCIMAGING.114.002942.

PMID:
25862716
6.

A Practical Review for Cardiac Rehabilitation Professionals of Continuous-Flow Left Ventricle Assist Devices: HISTORICAL AND CURRENT PERSPECTIVES.

Compostella L, Russo N, Setzu T, Bottio T, Compostella C, Tarzia V, Livi U, Gerosa G, Iliceto S, Bellotto F.

J Cardiopulm Rehabil Prev. 2015 Apr 7. [Epub ahead of print]

PMID:
25856733
7.

Effect of antihypertensive agents on risk of atrial fibrillation: a meta-analysis of large-scale randomized trials.

Emdin CA, Callender T, Cao J, Rahimi K.

Europace. 2015 Apr 7. pii: euv021. [Epub ahead of print]

PMID:
25855678
8.

Reliability of Oscillometric Blood Pressure Monitoring in Atrial Fibrillation Patients Admitted for Electric Cardioversion.

Maselli M, Giantin V, Corrado D, Franchin A, Attanasio F, Pengo V, Tramontano A, De Toni P, Perissinotto E, Manzato E.

J Clin Hypertens (Greenwich). 2015 Apr 9. doi: 10.1111/jch.12547. [Epub ahead of print]

PMID:
25855463
9.

Interaction of Blood Pressure and Body Mass Index With Risk of Incident Atrial Fibrillation in a Japanese Urban Cohort: The Suita Study.

Kokubo Y, Watanabe M, Higashiyama A, Nakao YM, Kobayashi T, Watanabe T, Okamura T, Okayama A, Miyamoto Y.

Am J Hypertens. 2015 Apr 6. pii: hpv038. [Epub ahead of print]

PMID:
25845964
10.

Use of bispectral index monitoring for determination of sedation depth in 50 patients undergoing cardioversion.

Kabukcu HK, Karakas MS, Yanikoglu A, Sahin N, Kabukcu M.

J Pak Med Assoc. 2014 Dec;64(12):1370-4.

PMID:
25842580
11.

[Why NAO: Know How. Why and how to choose the new oral anticoagulant in cardiological clinical practice].

Rossini R, Pecora D, Ferlini M, Gentile F, Moschini L, Pedrinazzi C, Ravizza P, Romano M, Canova P, Oliva F.

G Ital Cardiol (Rome). 2015 Mar;16(3):161-74. doi: 10.1714/1820.19826. Italian.

PMID:
25837460
12.

Renin-angiotensin system blockers in cardiac surgery.

Mangieri A.

J Crit Care. 2015 Mar 5. pii: S0883-9441(15)00080-5. doi: 10.1016/j.jcrc.2015.02.017. [Epub ahead of print]

PMID:
25813547
13.

[Prevention of cardiovascular diseases through sport and physical activity : A question of intensity?]

Wernhart S, Dinic M, Pressler A, Halle M.

Herz. 2015 Mar 26. [Epub ahead of print] German.

PMID:
25804555
14.

Minimizing the risk of hemorrhagic stroke during anticoagulant therapy for atrial fibrillation.

Zoppellaro G, Granziera S, Padayattil Jose S, Denas G, Bracco A, Iliceto S, Pengo V.

Expert Opin Drug Saf. 2015 Mar 24:1-13. [Epub ahead of print]

PMID:
25803739
15.

Cardiovascular complications secondary to graves' disease: a prospective study from ukraine.

Tsymbaliuk I, Unukovych D, Shvets N, Dinets A.

PLoS One. 2015 Mar 24;10(3):e0122388. doi: 10.1371/journal.pone.0122388. eCollection 2015.

16.

Beyond blood pressure: percutaneous renal denervation for the management of sympathetic hyperactivity and associated disease states.

McArdle MJ, deGoma EM, Cohen DL, Townsend RR, Wilensky RL, Giri J.

J Am Heart Assoc. 2015 Mar 23;4(3):e001415. doi: 10.1161/JAHA.114.001415. No abstract available.

17.

Digoxin use and risk of mortality in hypertensive patients with atrial fibrillation.

Okin PM, Hille DA, Wachtell K, Kjeldsen SE, Boman K, Dahlöf B, Devereux RB.

J Hypertens. 2015 Mar 19. [Epub ahead of print]

PMID:
25799208
18.

Metabolic determinants of white matter hyperintensity burden in patients with ischemic stroke.

Cloonan L, Fitzpatrick KM, Kanakis AS, Furie KL, Rosand J, Rost NS.

Atherosclerosis. 2015 May;240(1):149-53. doi: 10.1016/j.atherosclerosis.2015.02.052. Epub 2015 Mar 2.

PMID:
25795555
19.

Sustained pre-hypertensive blood pressure and incident atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis.

O'Neal WT, Soliman EZ, Qureshi W, Alonso A, Heckbert SR, Herrington D.

J Am Soc Hypertens. 2015 Mar;9(3):191-6. doi: 10.1016/j.jash.2015.01.001. Epub 2015 Jan 10.

PMID:
25795549
20.

Drug therapy of apparent treatment-resistant hypertension: focus on mineralocorticoid receptor antagonists.

Glicklich D, Frishman WH.

Drugs. 2015 Apr;75(5):473-85. doi: 10.1007/s40265-015-0372-3.

PMID:
25787734
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk